M

MAP Pharmaceuticals

0 followers

MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for patients suffering from conditions that are not adequately treated by currently available medicines. The company is developing LEVADEX™ inhaled therapy for the potential treatment of migraine and has reported positi... Read more

Headquarters

United States

Employees

51-200

Links


Org chart

Nelson
President and Chief Executive Officer
Collapse
Al Reppine
Senior Clinical Trial Manger
Lydia Shahbazian
Principal Packaging Engineer
Francie Brak-Myers
Pharmaceutical Research
Barbara Merritt
Clinical Contracts
Enas Hamdy Gad
Executive Secretary